Gazit CIRM Grant Figure 1 (IMAGE)
Caption
A Cedars-Sinai team of researchers led by principal investigator Dan Gazit, Ph.D., DMD, has been awarded a $5.18 million grant from California's stem cell research agency to advance stem cell technologies in segmental bone defects, a complex medical problem caused by large portions of bone tissue loss. The research team will use the grant from the California Institute for Regenerative Medicine to develop a novel approach to treat segmental bone defects without grafting bone. Stem cells will be recruited to the fracture site using a collagen matrix and then a bone-forming gene will be directly delivered to the stem cells using an ultrasound pulse. If successful, researchers will be able to proceed to clinical trials.
Credit
Cedars-Sinai
Usage Restrictions
None
License
Licensed content